Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
about
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
P2860
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@ast
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@en
type
label
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@ast
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@en
prefLabel
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@ast
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@en
P2093
P2860
P1433
P1476
Visceral Obesity Predicts Sign ...... nalcoholic Fatty Liver Disease
@en
P2093
Chung Yong Kim
Donghee Kim
Eun Ju Cho
Hwi Young Kim
Jeong-Hoon Lee
Jung Ho Kim
Kyoungbun Lee
Su Jong Yu
Yoon Jun Kim
P2860
P356
10.1097/MD.0000000000002159
P407
P577
2015-12-01T00:00:00Z